- Home
- SGRY
as 03-28-2025 4:00pm EST
Surgery Partners Inc is a healthcare services company with an integrated outpatient delivery model focused on providing quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. It operates in two segments: Surgical Facility Services and Ancillary Services out of which the Surgical Facility Services segment accounts for the majority of revenue.
| Founded: | 2004 | Country: | United States |
| Employees: | N/A | City: | BRENTWOOD |
| Market Cap: | 2.7B | IPO Year: | 2015 |
| Target Price: | $37.57 | AVG Volume (30 days): | 970.2K |
| Analyst Decision: | Buy | Number of Analysts: | 8 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.33 | EPS Growth: | N/A |
| 52 Week Low/High: | $19.50 - $33.97 | Next Earning Date: | 03-03-2025 |
| Revenue: | $3,114,300,000 | Revenue Growth: | 13.52% |
| Revenue Growth (this year): | 10.62% | Revenue Growth (next year): | 9.29% |
Stock Insider Trading Activity of Surgery Partners Inc. (SGRY)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Baldock Jennifer | SGRY | Chief Admin & Dev Officer | Mar 14 '25 | Sell | $23.94 | 612 | $14,651.28 | 236,047 | |
| Webb William Trenton | SGRY | American Group President | Mar 14 '25 | Sell | $23.70 | 138 | $3,270.60 | 74,521 | |
| Doherty David T | SGRY | Chief Financial Officer | Mar 10 '25 | Sell | $24.02 | 6,733 | $161,726.66 | 150,868 | |
| Burkhalter Danielle | SGRY | Chief Human Resources Officer | Mar 10 '25 | Sell | $24.14 | 1,240 | $29,933.60 | 44,913 | |
| Baldock Jennifer | SGRY | Chief Admin & Dev Officer | Mar 10 '25 | Sell | $23.97 | 3,008 | $72,101.76 | 236,047 | |
| Brittenham Marissa | SGRY | Chief Strategy Officer | Mar 10 '25 | Sell | $24.09 | 3,156 | $76,028.04 | 63,408 | |
| Bane Harrison R. | SGRY | National Group President | Mar 10 '25 | Sell | $24.16 | 4,045 | $97,727.20 | 126,520 | |
| Webb William Trenton | SGRY | American Group President | Mar 10 '25 | Sell | $24.06 | 2,057 | $49,491.42 | 74,521 | |
| Doherty David T | SGRY | Chief Financial Officer | Feb 7 '25 | Sell | $25.61 | 13,641 | $349,346.01 | 150,868 | |
| Evans Jason Eric | SGRY | Chief Executive Officer | Feb 7 '25 | Sell | $25.65 | 26,520 | $680,238.00 | 560,698 |
Latest Surgery Partners Inc. News
SGRY Breaking Stock News: Dive into SGRY Ticker-Specific Updates for Smart Investing
MT Newswires
18 days ago
Macquarie Trims Price Target on Surgery Partners to $33 From $34, Keeps Outperform Rating
MT Newswires
24 days ago
UBS Cuts Price Target on Surgery Partners to $34 From $38, Keeps Buy Rating
GuruFocus.com
25 days ago
Surgery Partners Inc (SGRY) Q4 2024 Earnings Call Highlights: Record Revenue and Strategic Expansion
Thomson Reuters StreetEvents
25 days ago
Q4 2024 Surgery Partners Inc Earnings Call
Zacks
25 days ago
Surgery Partners (SGRY) Q4 Earnings and Revenues Surpass Estimates
MT Newswires
25 days ago
Surgery Partners Adjusted Net Income Flat, Revenue Increases; 2025 Outlook Issued
StockStory
25 days ago
Surgery Partners (NASDAQ:SGRY) Exceeds Q4 Expectations
Associated Press Finance
25 days ago
Surgery Partners: Q4 Earnings Snapshot
Compare SGRY vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "SGRY Surgery Partners Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.